![Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study - The Lancet Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study - The Lancet](https://www.thelancet.com/cms/attachment/9ca28e0e-fbe0-4800-ab5c-27eaf03065bd/gr1_lrg.jpg)
Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study - The Lancet
![SYMBICORT 160/4.5 (Budesonide, Formoterol) Dosage & Rx Info, Uses | SYMBICORT 160/4.5 Side Effects - MPR SYMBICORT 160/4.5 (Budesonide, Formoterol) Dosage & Rx Info, Uses | SYMBICORT 160/4.5 Side Effects - MPR](https://www.empr.com/wp-content/uploads/sites/7/2018/12/feb3e833ec6d49bdb68c34299c5614b3-symbicort_box_i.jpg)
SYMBICORT 160/4.5 (Budesonide, Formoterol) Dosage & Rx Info, Uses | SYMBICORT 160/4.5 Side Effects - MPR
![The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada | Allergy, Asthma & Clinical Immunology | Full Text The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada | Allergy, Asthma & Clinical Immunology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13223-021-00610-w/MediaObjects/13223_2021_610_Fig1_HTML.png)
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada | Allergy, Asthma & Clinical Immunology | Full Text
![Using Symbicort Rapihaler (budesonide–formoterol) puffer for an asthma attack - National Asthma Council Australia Using Symbicort Rapihaler (budesonide–formoterol) puffer for an asthma attack - National Asthma Council Australia](https://d8z57tiamduo7.cloudfront.net/images/Sym-Rapihaler_50_3.png)
Using Symbicort Rapihaler (budesonide–formoterol) puffer for an asthma attack - National Asthma Council Australia
![Easyhaler Budesonide 100micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) 200 dose - RightBreathe Easyhaler Budesonide 100micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) 200 dose - RightBreathe](https://www.rightbreathe.com/wp-content/uploads/2016/06/Easyhaler_Budesoniude_100mcg_pack_image.jpg)
Easyhaler Budesonide 100micrograms/dose dry powder inhaler (Orion Pharma (UK) Ltd) 200 dose - RightBreathe
![Second study confirms benefits of budesonide in early stages of COVID-19 | NIHR Oxford Biomedical Research Centre Second study confirms benefits of budesonide in early stages of COVID-19 | NIHR Oxford Biomedical Research Centre](https://oxfordbrc.nihr.ac.uk/wp-content/uploads/2021/08/Budesonide-pic-11.2.2021-06.png)
Second study confirms benefits of budesonide in early stages of COVID-19 | NIHR Oxford Biomedical Research Centre
![Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/c8a53fd8-7246-40de-acd7-9d497f8dee0c/gr1_lrg.gif)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
![Two-Drug Inhaler Could Reduce Asthma Attacks. | Institute for Translational Medicine and Science | Rutgers University Two-Drug Inhaler Could Reduce Asthma Attacks. | Institute for Translational Medicine and Science | Rutgers University](https://ritms.rutgers.edu/wp-content/uploads/Inhaler-combining-albuterol-budesonide-may-stop-asthma-attacks.jpg)